Dalkia is committed to designing and implementing customer centric innovative solutions that can improve our customer's bottom line. With over 6,150 hospitals under current management worldwide, Dalkia is familiar with the specific requirements and challenges of healthcare executives and technicians, particularly in relation to surgical instruments reprocessing & sterilization services.
Dalkia Canada has created SteriPro, a company dedicated to providing outsourced surgical instruments reprocessing and sterilization services. SteriPro's is based on the ongoing 10-year success in the stringent European healthcare market of Dalkia's own subsidiary, Sterience. Offering a total capability, SteriPro finances, builds, owns and operates purpose-designed sterilization facilities within or close to your healthcare centres. Services will be delivered under the Sterience brandname.
SteriPro's first sterilization centre will be fully operational in spring 2011 and will serve the sterilization requirements of Toronto-based hospitals while providing highly valuable jobs. This centre will be followed by satellite centres for optimized service delivery.
SteriPro's commitment to Zero Defects and Instrument Traceability provides a reliable and cost effective solution to hospitals' executives who face serious financial and operating challenges:
- Shortage of and high turnover of sterilization personnel,
- High training costs,
- Limited and expensive operating space,
- Sophisticated and increasingly capital intensive technical equipment,
- Rising sanitary standards, and
- Shortfall of capital for new equipment.